anti-TSHR antibody
RTW-backed startup Yarrow Bioscience signs autoimmune antibody deal with China’s GenSci
RTW Investments; Yarrow Bioscience; GenSci; Changchun GeneScience Pharmaceutical; autoimmune; antibody; GS-098; YB-101; anti-TSHR antibody; thyroid eye disease; China; ex-China rights; strategic partnership; licensing deal